A COMBINED flu and Covid vaccine is more practical than separate single injections, its maker says.
The findings elevate hopes that the two-in-one jab will probably be accepted by regulators for an NHS rollout this yr.
1
Moderna’s Spikevax vaccine for Covid is utilized in NHS booster programmes.
However a more recent model additionally features a dose of flu safety.
Newest assessments from Moderna confirmed the mRNA-1083 vaccine led to greater immune responses towards each flu and Covid than when having two separate single jabs.
Fewer injections can be extra handy and easier, making it extra probably folks would get vaccinated, the corporate says.
Moderna’s trial concerned two teams of 4,000 folks every, aged 50-plus.
The side-effects had been gentle — a sore arm and tiredness — as is typical with such jabs.
Chief govt Stephane Bancel stated: “We’re very delighted in regards to the outcomes.
“You get one dose, one needle which implies ease and peace of thoughts for the patron.”
Opponents Pfizer and BioNTech are additionally testing an analogous two-in-one vaccine towards flu and Covid.
